• Home
  • NEW DAY MEDICINE
  • 12(50)2022
  • 121 -12 (50) 2022 — Mustafayeva Sh.A., Saidova M.M. — NSAID ASSOCIATED WITH RENAL DAMAGE IN PATIENTS WITH RHEUMOTOID ARTHRITIS

121 -12 (50) 2022 — Mustafayeva Sh.A., Saidova M.M. — NSAID ASSOCIATED WITH RENAL DAMAGE IN PATIENTS WITH RHEUMOTOID ARTHRITIS

NSAID ASSOCIATED WITH RENAL DAMAGE IN PATIENTS WITH RHEUMOTOID ARTHRITIS

Mustafayeva Sh.A., Bukhara State Medical Institute

Saidova M.M. Bukhara State Medical Institute

Resume

Kidney disease is very common in patients with rheumatic relapses and can be transmitted either by the disease itself or by a secondary disease encountered at presentation. The prevalence of renal manifestation and its severity depend on severe diseases, as well as on the aggressiveness of therapy. For most rheumatic diseases, kidney damage portends a poor prognosis and requires aggressive immunosuppressive treatment. On the other hand, it is almost impossible to group NSPs by greater or lesser adverse effects on the kidneys – there are very few comparative scientific studies. Thus, it is important to diagnose and treat them at an early stage. But it can be argued that almost all NSPS (including selective COX-2 inhibitors) have side effects on the kidneys.

Key words: rheumatoid arthritis, nephropathy, chronic kidney disease, non-steroidal anti-inflammatory drugs.

First page

703

Last page

710

For citation: Mustafayeva Sh.A., Saidova M.M. – NSAID ASSOCIATED WITH RENAL DAMAGE IN PATIENTS WITH RHEUMOTOID ARTHRITIS //New Day in Medicine 12(50)2022 https://clck.ru/33Gtgh

LIST OF REFERENCES:

  1. Akhmadovna M.S. Reasons for the Development of Morphostructural Changes in Kidney Cells in Patients with Rheumatoid Arthritis //Vital Annex: International Journal of Novel Research in Advanced Sciences. – 2022. – Т. 1. – №. 5. – С. 396-401.
  2. Axmatovna M. S. et al. Peculiarities of the morphophenotype and characteristics of the physical performance of young football players and their relationship with the gaming amplitude //Academicia: an international multidisciplinary research journal. – 2021. – Т. 11. – №. 2. – С. 1381-1388. 
  3. Axmadovna M.S. Features of the morphophenotype and characteristics of the physical performance of young football players and their relationship with the playing role //European journal of modern medicine and practice. 2022. – Т. 2. – №. 3. – С. 1-5.
  4. Cheng H.F., Harris R.C. Cyclooxygenase the kidney and hypertension //Hypertension. 2004. Vol. 43. Р. 525–530.
  5. Delmas P.D. Non-steroidal anti-infl amatory drugs and renal function //Br. J. Rheumatol. 1995. Vol. 34. № 1. Р. 25.
  6. Dubach U.C., Rosner B., Sturmer T. An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987) //N. Engl. J. Med. 1991. Vol. 324. Р. 115–160.
  7. Elseviers M.M., De Broe M.E. A long-term prospective controlled study of analgesic abuse in Belgium //Kidney Int. 1995. Vol. 48. Р. 1912–1919.
  8. Graham M.G. Acute renal failure to high-dose celecoxib //Ann. Intern. Med. 2001. Vol. 135. Р. 69–70;
  9. Alper A.B., Meleg-Smith S., Krane N.K. Nephrotic syndrome and interstitial nephritis associated with celecoxib //Am. J. Kidney Dis. 2002. Vol. 40. Р. 1086–1090;
  10. Szalat A., Krasilnikov I., Bloch A. et al. Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature //Arthritis Rheum. 2004. Vol. 51. № 4. Р. 670–673.
  11. Griffi M.R., Yared A., Waynea A.R. Non-steroidal anti-infl ammatory drugs and acute renal failure in elderly persons //Am. J. Ehidemiol. 2000. Vol. 151.10.Р. 488–496;
  12. Kolhagen J., Katrib A., Stafford L.et al. Does regular use of non-steroidal antiinfl ammatory drugs increase the risk of renal disease? // Nephrology. 2002. Vol. 7. № 1. Р. 5–11.
  13. Harries R.C. Cyclooxygenase-2 inhibition and renal physiology //Am J.  Cardiol. 2002. Vol. 89. Р. 10–17.
  14. Hickson L.J., Crowson C.S., Gabriel S.E. et al. Development of reduced kidney function in rheumatoid arthritis. //Am J Kidney Dis. 2014; 63:206-13. doi: 0.1053/j.ajkd.2013.08.010 
  15. Jonson A.G., Nguyen T.V., Day R.O. Do nonsteroidal anti-infl ammatory drugs affect blood pressure? A meta-analysis //Ann. Intern. Med. 1994. Vol. 121. Р. 289–300;
  16. Pope J.E., Anderson J.J., Felson D.T. A meta-analysis of the effect of nonsteroidal anti-inf lammatory drugs on blood pressure // Arch. Intern. Med. 1993. Vol. 153. P. 477–484.
  17. Kholmurodovich U.F. Liver Fibrosis-Modern Methods of Diagnostics and Drug Correction //Central asian journal of medical and natural sciences. – 2021; 2(2)158-167.
  18. Lewis S.C., Langman M.L., Laporte J.R. et al. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient date //Br. J. Clin. Pharmacol. 2002. Vol. 54. Р. 320–326;
  19. Pedersen A.K., FitzGerald G.A. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase // N. Engl. J. Med. 1984. Vol. 311. Р. 1206–1211.
  20. Lydford S., McKechnie K., Dougall I.Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery //Br. J. Pharmcol. 1996. Vol. 117. Р. 13–20.

file

download